These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 8539244
1. Crystallization and X-ray diffraction data of the cleaved form of plasminogen activator inhibitor-1. Aertgeerts K, De Bondt HL, De Ranter C, Declerck PJ. Proteins; 1995 Sep; 23(1):118-21. PubMed ID: 8539244 [Abstract] [Full Text] [Related]
2. Crystallization and preliminary X-ray diffraction analysis of two conformations of intact human antithrombin. Wardell MR, Abrahams JP, Bruce D, Skinner R, Leslie AG. J Mol Biol; 1993 Dec 20; 234(4):1253-8. PubMed ID: 8263926 [Abstract] [Full Text] [Related]
3. Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation. Nar H, Bauer M, Stassen JM, Lang D, Gils A, Declerck PJ. J Mol Biol; 2000 Mar 31; 297(3):683-95. PubMed ID: 10731421 [Abstract] [Full Text] [Related]
4. Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop. Gils A, Knockaert I, Declerck PJ. Biochemistry; 1996 Jun 11; 35(23):7474-81. PubMed ID: 8652525 [Abstract] [Full Text] [Related]
5. Structural basis of latency in plasminogen activator inhibitor-1. Mottonen J, Strand A, Symersky J, Sweet RM, Danley DE, Geoghegan KF, Gerard RD, Goldsmith EJ. Nature; 1992 Jan 16; 355(6357):270-3. PubMed ID: 1731226 [Abstract] [Full Text] [Related]
6. Crystallization and preliminary X-ray analysis of cholesterol oxidase from Brevibacterium sterolicum containing covalently bound FAD. Croteau N, Vrielink A. J Struct Biol; 1996 Jan 16; 116(2):317-9. PubMed ID: 8812988 [Abstract] [Full Text] [Related]
7. Crystallization and preliminary X-ray analysis of inorganic pyrophosphatase from the hyperthermophilic archaeon Pyrococcus horikoshii OT3. Liu B, Li X, Gao R, Zhou W, Xie G, Bartlam M, Pang H, Feng Y, Rao Z. Acta Crystallogr D Biol Crystallogr; 2004 Mar 16; 60(Pt 3):577-9. PubMed ID: 14993699 [Abstract] [Full Text] [Related]
8. Preliminary X-ray analysis of crystals of plasminogen activator inhibitor-1. Goldsmith EJ, Sheng-Cheng C, Danley DE, Gerard RD, Geoghegan KF, Mottonen J, Strand A. Proteins; 1991 Mar 16; 9(3):225-7. PubMed ID: 2006140 [Abstract] [Full Text] [Related]
9. Crystallization and preliminary X-ray diffraction studies of recombinant human interleukin-5. Hassell AM, Wells TN, Graber P, Proudfoot AE, Anderegg RJ, Burkhart W, Jordan SR, Milburn MV. J Mol Biol; 1993 Feb 20; 229(4):1150-2. PubMed ID: 8445640 [Abstract] [Full Text] [Related]
10. VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form. Jankun J, Aleem AM, Selman SH, Basrur V, Skrzypczak-Jankun E. Int J Mol Med; 2009 Jan 20; 23(1):57-63. PubMed ID: 19082507 [Abstract] [Full Text] [Related]
11. Crystallization and preliminary x-ray analysis of recombinant staphylokinase. Rabijns A, Baeyens K, De Bondt HL, De Ranter C. Proteins; 1997 Jan 20; 27(1):160-1. PubMed ID: 9037722 [Abstract] [Full Text] [Related]
12. Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries. Stoop AA, Eldering E, Dafforn TR, Read RJ, Pannekoek H. J Mol Biol; 2001 Jan 26; 305(4):773-83. PubMed ID: 11162091 [Abstract] [Full Text] [Related]
13. Solvent effects on activity and conformation of plasminogen activator inhibitor-1. Andreasen PA, Egelund R, Jensen S, Rodenburg KW. Thromb Haemost; 1999 Mar 26; 81(3):407-14. PubMed ID: 10102470 [Abstract] [Full Text] [Related]
14. Crystallization and preliminary X-ray diffraction studies of leishmanolysin, the major surface metalloproteinase from Leishmania major. Schlagenhauf E, Etges R, Metcalf P. Proteins; 1995 May 26; 22(1):58-66. PubMed ID: 7675788 [Abstract] [Full Text] [Related]
15. Purification, crystallization and preliminary X-ray diffraction analysis of human enolase-phosphatase E1. Wang H, Pang H, Ding Y, Li Y, Wu X, Rao Z. Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 May 01; 61(Pt 5):521-3. PubMed ID: 16511085 [Abstract] [Full Text] [Related]
16. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1. Wardell MR, Chang WS, Bruce D, Skinner R, Lesk AM, Carrell RW. Biochemistry; 1997 Oct 21; 36(42):13133-42. PubMed ID: 9335576 [Abstract] [Full Text] [Related]
17. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop. Dekker RJ, Eichinger A, Stoop AA, Bode W, Pannekoek H, Horrevoets AJ. J Mol Biol; 1999 Oct 29; 293(3):613-27. PubMed ID: 10543954 [Abstract] [Full Text] [Related]
19. Crystallization and preliminary X-ray diffraction analysis of UDP-N-acetylglucosamine enolpyruvyltransferase of Enterobacter cloacae. Sack S, Dauter Z, Wanke C, Amrhein N, Mandelkow E, Schönbrunn E. J Struct Biol; 1996 Jan 29; 117(1):73-6. PubMed ID: 8776890 [Abstract] [Full Text] [Related]
20. Plasminogen activator inhibitor 1 (PAI-1) in its active conformation: crystallization and preliminary X-ray diffraction data. Willems PK, Rabijns A, Aertgeerts K, Vleugels N, Knockaert I, De Bondt HL, De Ranter CJ, Declerck PJ. Acta Crystallogr D Biol Crystallogr; 1999 Feb 29; 55(Pt 2):574-6. PubMed ID: 10089384 [Abstract] [Full Text] [Related] Page: [Next] [New Search]